Indo Borax Q3 FY26 Consolidated Revenue at ₹4,102.42 Lakhs
Indo Borax & Chemicals Ltd. reported consolidated revenue of ₹4,102.42 lakhs for Q3 FY26, up from ₹3,750.74 lakhs in Q3 FY25. Consolidated net profit was ₹927.19 lakhs. For the nine months, consolidated revenue was ₹15,244.04 lakhs with a net profit of ₹3,573.75 lakhs. Standalone revenue was ₹4,102.42 lakhs with a net profit of ₹911.11 lakhs for the quarter.
The financial results show growth, which is material for investors. However, there are no extraordinary events like major acquisitions or significant new orders that would warrant a 'HIGH' impact.
The company reported an increase in revenue and profit for the quarter and nine months ended December 31, 2025, compared to the previous year, indicating positive financial performance.
Indo Borax & Chemicals Ltd. announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved the standalone and consolidated financial results during a meeting held on January 16, 2026.
For the third quarter of FY26, the company reported a consolidated revenue from operations of ₹4,102.42 lakhs, an increase from ₹3,750.74 lakhs in the same period last year. Total income for the quarter stood at ₹4,535.12 lakhs. The consolidated net profit for the quarter was ₹927.19 lakhs. For the nine-month period ended December 31, 2025, consolidated revenue from operations was ₹15,244.04 lakhs, with a net profit of ₹3,573.75 lakhs.
On a standalone basis, revenue from operations for the quarter ended December 31, 2025, was ₹4,102.42 lakhs, and the net profit was ₹911.11 lakhs. For the nine-month period, standalone revenue from operations was ₹15,244.04 lakhs, and the net profit was ₹3,523.70 lakhs.
The company also noted that its Pithampur Plant was shut down from October 14, 2025, to November 22, 2025, for planned annual maintenance. Additionally, a one-time impact of new Labour Codes resulted in a decrease in the provision for employee benefits by ₹27.97 lakhs, recognized as an employee benefit expense in the current reporting period.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.